Insmed (INSM) Non Operating Income (2013 - 2026)
Insmed (INSM) recorded quarterly Non Operating Income of -$736000.0 in Q1 2026, up 59.63% quarter-over-quarter from -$1.8 million in Q4 2025, and down 657.58% on a YoY basis from $132000.0 in Q1 2025.
Insmed (INSM) Non Operating Income (2013 - 2026) Analysis & Trends
Insmed's Non Operating Income history runs 14 years deep, the most recent figure standing at -$736000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 657.58% year-over-year to -$736000.0; the TTM figure through Mar 2026 stood at -$2.7 million (down 314.83% YoY), while the FY2025 annual figure was -$1.8 million, down 6448.28% from the prior year.
- Non Operating Income was -$736000.0 for Q1 2026 at Insmed, up from -$1.8 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.2 million in Q4 2023 to a low of -$4.3 million in Q2 2022.
- Historically, Non Operating Income has averaged -$390058.8 across 5 years, with a median of -$445000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income sank 2804.65% in 2022, then surged 546.67% in 2024.
- A 5-year view of Non Operating Income shows it stood at $1.1 million in 2022, then soared by 92.04% to $2.2 million in 2023, then sank by 120.51% to -$445000.0 in 2024, then plunged by 309.66% to -$1.8 million in 2025, then surged by 59.63% to -$736000.0 in 2026.
- The last three Non Operating Income figures came in at -$736000.0 (Q1 2026), -$1.8 million (Q4 2025), and -$603000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Insmed | 21.32 Bn | 20.09 Bn | 258.54 Mn | -736,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -736,000.00 |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | -603,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | -445,000.00 |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | -269,000.00 |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 2.17 Mn |
| Sep 30, 2023 | 285,000.00 |
| Jun 30, 2023 | -488,000.00 |
| Mar 31, 2023 | -111,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | -1.51 Mn |
| Jun 30, 2022 | -4.31 Mn |
| Mar 31, 2022 | -1.25 Mn |
| Dec 31, 2021 | -2.65 Mn |
| Sep 30, 2021 | -476,000.00 |
| Jun 30, 2021 | -159,000.00 |